Legal & General Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-18,500
Closed -$16K 3516
2020
Q1
$16K Sell
18,500
-4,750
-20% -$6.79K ﹤0.01% 3011
2019
Q4
$38K Buy
23,250
+2,994
+15% +$4.5K ﹤0.01% 2936
2019
Q3
$23K Buy
20,256
+4,451
+28% +$5.15K ﹤0.01% 3098
2019
Q2
$20K Buy
15,805
+6,667
+73% +$8.49K ﹤0.01% 3201
2019
Q1
$13K Hold
9,138
﹤0.01% 3213
2018
Q4
$11K Hold
9,138
﹤0.01% 3265
2018
Q3
$12K Hold
9,138
﹤0.01% 3308
2018
Q2
$21K Buy
9,138
+3,396
+59% +$6.56K ﹤0.01% 3184
2018
Q1
$9K Sell
5,742
-3,066
-35% -$3.59K ﹤0.01% 3226
2017
Q4
$6K Hold
8,808
﹤0.01% 3257
2017
Q3
$11K Hold
8,808
﹤0.01% 3274
2017
Q2
$15K Hold
8,808
﹤0.01% 3263
2017
Q1
$23K Sell
8,808
-480
-5% -$1.72K ﹤0.01% 3044
2016
Q4
$39K Buy
9,288
+6,222
+203% +$20.5K ﹤0.01% 2947
2016
Q3
$8K Hold
3,066
﹤0.01% 2856
2016
Q2
$5K Hold
3,066
﹤0.01% 2899
2016
Q1
$7K Hold
3,066
﹤0.01% 2757
2015
Q4
$11K Hold
3,066
﹤0.01% 2764
2015
Q3
$18K Buy
+3,066
New +$20.8K ﹤0.01% 2727

Other funds holding GEN

Legal & General Group's GEN Position: Q2 2020 in Review

Legal & General Group sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 18,500 shares — an estimated $16K sold.

Legal & General Group first reported a position in GEN in Q3 2015 and held it in 19 quarters. The position peaked at $39K in Q4 2016. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

  • Legal & General Group reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
  • Legal & General Group sold 18,500 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $16K.
  • Legal & General Group first reported a position in Genesis Healthcare, Inc. in Q3 2015 and held it in 19 quarters.
  • Legal & General Group's Genesis Healthcare, Inc. position peaked at $39K in Q4 2016.
  • 58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.